600566.SS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:00):

Stats
今日成交量	9.22M
平均成交量	7.85M
市值	36.80B
EPS	CNY0.658 ( 2023-10-22 )
下一个收益日期	( CNY0 ) 2024-05-08
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	12.32
ATR14	CNY0.0400 (0.10%)

音量相关性

長: -0.02 (neutral)

短: -0.59 (weak negative)

Signal:(39.596) Neutral

Hubei Jumpcan 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hubei Jumpcan 相关性 - 货币/商品

-0.20
( neutral )

-0.55
( weak negative )

0.00
( neutral )

-0.12
( neutral )

-0.39
( neutral )

Hubei Jumpcan 财务报表

Annual	2023
营收:	CNY9.51B
毛利润:	CNY7.60B (79.92 %)
EPS:	CNY3.08

FY	2023
营收:	CNY9.51B
毛利润:	CNY7.60B (79.92 %)
EPS:	CNY3.08

FY	2022
营收:	CNY9.00B
毛利润:	CNY7.46B (82.91 %)
EPS:	CNY2.44

FY	2021
营收:	CNY7.63B
毛利润:	CNY6.35B (83.27 %)
EPS:	CNY2.06

Financial Reports:

No articles found.

Hubei Jumpcan

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis. The company was formerly known as Hubei Hongcheng General Machinery Co., Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co., Ltd. in March 2015. Hubei Jumpcan Pharmaceutical Co., Ltd. is based in Taixing, China.